Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Kronos Bio is dedicated to the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets. Leveraging industry-leading research into high-throughput screening strategies for chemical modulators of transcription factors and other challenging targets in oncology, Kronos utilizes its small molecule microarray (SMM) platform and extensive know-how in biological assay development to pursue novel therapies against some of the most important and intractable targets in cancer research.

Key Contact
Name
Title
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
07/18/19 $105,000,000 Series A Vida Ventures
undisclosed